0001752724-21-194564.txt : 20210913 0001752724-21-194564.hdr.sgml : 20210913 20210913172151 ACCESSION NUMBER: 0001752724-21-194564 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210913 DATE AS OF CHANGE: 20210913 EFFECTIVENESS DATE: 20210913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Highland Funds I CENTRAL INDEX KEY: 0001354917 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-21866 FILM NUMBER: 211250508 BUSINESS ADDRESS: STREET 1: 2515 MCKINNEY AVENUE STREET 2: SUITE 1100 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 833-697-6246 MAIL ADDRESS: STREET 1: 2515 MCKINNEY AVENUE STREET 2: SUITE 1100 CITY: DALLAS STATE: TX ZIP: 75201 FORMER COMPANY: FORMER CONFORMED NAME: PYXIS FUNDS I DATE OF NAME CHANGE: 20120109 FORMER COMPANY: FORMER CONFORMED NAME: Highland Funds I DATE OF NAME CHANGE: 20060302 0001354917 S000021242 Highland Healthcare Opportunities Fund C000060521 Class A HHCAX C000060522 Class C HHCCX C000060523 Class Z HHCZX 0001354917 S000038289 Highland/iBoxx Senior Loan ETF C000118182 Highland/iBoxx Senior Loan ETF SNLN 0001354917 S000045651 Highland Opportunistic Credit Fund C000141934 Class A HNRAX C000141935 Class C HNRCX C000141936 Class Z HNRZX 0001354917 S000054634 NexPoint Merger Arbitrage Fund C000171609 Class A HMEAX C000171610 Class C HMECX C000171611 Class Z HMEZX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001354917 XXXXXXXX 811-21866 false false false N-1A true Highland Funds I 811-21866 0001354917 549300D4RVXJJ0JOL180 200 CRESCENT COURT SUITE 700 DALLAS 75201 US-TX US 972-628-4100 Highland Capital Management Fund Advisors, L.P. 300 Crescent Court Suite 700 Dallas 75201 1-877-665-1287 Records as Advisor and Administrator for Trust The Bank of New York Mellon 240 Greenwich Street New York 10286 1-212-495-1784 Records as Custodian for Trust DST Asset Manager Solutions, Inc. 311 W. 11th Street Kansas City 64105 816-435-1000 Records As Transfer Agent For Trust BNY Mellon Investment Servicing (US) Inc. 240 Greenwich Street New York 10286 1-212-495-1784 Records As Transfer Agent For Trust SEI Investments Distribution Co. 1 Freedom Valley Drive OAKS 19456 610-676-1000 Records as Distributor for Trust SEI INVESTMENTS GLOBAL FUNDS SERVICES 1 Freedom Valley Drive OAKS 19456 610-676-1000 Records as Sub-Administrator for Trust N N N-1A 3 N Ethan Powell 000000000 N John Honis 000000000 Y Dr. Bob Froehlich 000000000 N Bryan A. Ward 000000000 N Jason Post N/A 200 Crescent Court Suite 700 Dallas 75201 XXXXXX N N N N N N NexPoint Securities, Inc 8-69128 000165013 00000000000000000000 Y SEI INVESTMENTS DISTRIBUTION CO. 8-27897 000010690 N/A N N Cohen & Company, Ltd. 600 N/A N N N N N N N Highland Healthcare Opportunities Fund S000021242 549300G5T2BUVOTD6774 N 3 0 0 N/A Y N Y N N BNY Mellon HPFHU0OQ28E4N0NFVK49 N N Revenue sharing split 1115459.25 2982.00000000 Rule 22d-1 (17 CFR 270.22d-1) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) N N N N Highland Capital Management Fund Advisors, L.P. 801-69968 000149653 5493002K2NSYVU046L11 N DST Systems, Inc. 084-00448 21B7QCD05XOK0YTYOP98 N N N S&P 549300U4VWNITEKO2881 N Thomson Reuters Corporation 549300561UZND4C7B569 CA N Pricing Direct 549300WIC0TOJ7N7GD54 N Bloomberg 254900BF4G8VMW8GG471 N IHS Markit 549300HLPTRASHS0E726 GB N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N DST Asset Manager Solutions, Inc. 084-00896 SEC file number N N N SEI Investments Global Funds Services 801-24593 SEC File Number N Y Highland Capital Management Fund Advisors, L.P. 5493002K2NSYVU046L11 Y N N Highland Capital Funds Distributor Inc 8-69128 000165013 N/A 0.00 NexBank Securities, Inc. 8-66705 000133267 5493000R7PCXD7JZMO73 0.00 SEI Investments Distribution Co. 8-27897 000010690 N/A 0.00 PIPER JAFFRAY 008-15204 000000665 549300GRQCWQ3XGH0H10 2779.72000000 MERRILL LYNCH, PIERCE, FENNER & SMITH 008-07221 000007691 8NAV47T0Y26Q87Y0QP81 18966.13000000 SOCIETE GENERALE COWEN SECURITIES CORP. 008-40756 000023857 5493008QI0EFC5WBED75 4466.39999999 OPPENHEIMER & ASSOCIATES 008-31756 000015168 254900vh02jqr2l8xd64 12684.08000000 VIRTU FINANCIAL BD LLC 8-60815 000148390 54930088MP91YZQJT494 16188.78000000 SUNTRUST 008-47518 000036888 IYDOJBGJWY9T8XKCSX06 4913.64000000 INTERNATIONAL STRATEGY & INVESTMENT GROUP 8-43515 000028195 N/A 5300.00000000 STIFEL NICOLAUS & CO., INC. 008-01447 000000793 5WUVMA08EYG4KEUPW589 3278.44000000 J.P. MORGAN SECURITIES 008-35008 000000079 ZBUT11V806EZRVTWT807 11982.96000000 LEERINK SWANN AND COMPANY 008-48535 000039011 549300AAH7U76CEUBI94 22968.20000000 116942.75000000 0.00000000 N 26016835.85000000 N N N N Highland/iBoxx Senior Loan ETF S000038289 254900KZ9XGLUQ76VB43 N 1 0 0 Exchange-Traded Fund N N -3.06 -3.71 16.03774414 14.6163696 Y N N N N/A N/A N/A Rule 22d-1 (17 CFR 270.22d-1) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) Y Y Y N Highland Capital Management Fund Advisors, L.P. 801-69968 000149653 5493002K2NSYVU046L11 N BNY Mellon Investment Servicing (US) Inc. 084-01761 549300CFZQLI9QMJ1Z03 N N N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N S&P 549300U4VWNITEKO2881 N IHS Markit 549300HLPTRASHS0E726 GB N Thomson Reuters Corporation 549300561UZND4C7B569 CA N Pricing Direct 549300WIC0TOJ7N7GD54 N Bloomberg 254900BF4G8VMW8GG471 N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N SEI Investments Distribution Co. 008-27897 SEC File Number Y N N SEI INVESTMENTS GLOBAL FUNDS SERVICES 801-24593 SEC FILE NUMBER N N N NexBank Securities, Inc. 8-66705 000133267 5493000R7PCXD7JZMO73 0.00 SEI Investments Distribution Co. 8-27897 000010690 N/A 0.00 Highland Capital Funds Distributor Inc 8-69128 000165013 N/A 0.00 0.00000000 BANK OF AMERICA 008-69787 000283942 549300HN4UKV1E2R3U73 73428163.64 BARCLAYS CAPITAL INC. 008-41342 000019714 AC28XWWI3WIBK2824319 55862356.41 MORGAN STANLEY SMITH BARNEY LLC 008-15869 000111386 549300RG2G4JJSK1V155 38498790.32 CITIGROUP GLOBAL MARKETS 008-08177 000007059 MBNUM2BPBDO7JBLYG310 26901102.74 JP MORGAN 008-35008 000000079 ZBUT11V806EZRVTWT807 13835218.92 DEUTSCHE BANK SECURITIES, INC. 008-17822 000002525 9J6MBOOO7BECTDTUZW19 8712665.92 BANK OF NOVA SCOTIA 008-03716 000002739 549300BLWPABP1VNME36 5573875 JEFFERIES LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 4422777.95 NOMURA SECURITIES INTERNATIONAL, INC. 008-15255 000004297 OXTKY6Q8X53C9ILVV871 2390125 MERRILL LYNCH, PIERCE, FENNER & SMITH 008-07221 000007691 8NAV47T0Y26Q87Y0QP81 1243668.57 611837507.99000001 N 61373474.54999999 N N N NexPoint Merger Arbitrage Fund S000054634 549300O24D7XG2BMWB63 N 3 0 0 N/A Y N Y N N BNY Mellon HPFHU0OQ28E4N0NFVK49 N N Revenue sharing split 2234482.55 20322.00000000 Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 22d-1 (17 CFR 270.22d-1) Y Y Y N Highland Capital Management Fund Advisors, L.P. 801-69968 000149653 5493002K2NSYVU046L11 N DST Asset Manager Solutions, Inc. 084-00896 N/A N N N S&P 549300U4VWNITEKO2881 N Thomson Reuters Corporation 549300561UZND4C7B569 CA N Bloomberg 254900BF4G8VMW8GG471 N IHS Markit 549300HLPTRASHS0E726 GB N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N Pricing Direct 549300WIC0TOJ7N7GD54 N N Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N DST Asset Manager Solutions, Inc. 084-00896 SEC file number N N N Highland Capital Management Fund Advisors, L.P. 5493002K2NSYVU046L11 Y N SEI Investments Global Funds Services 801-24593 SEC File Number N Y N SEI Investments Distribution Co. 8-27897 000010690 N/A 0.00 Highland Capital Funds Distributor Inc 8-69128 000165013 N/A 0.00 NexBank Securities, Inc. 8-66705 000133267 5493000R7PCXD7JZMO73 0.00 CANTOR FITZGERALD & CO. 008-00201 000000134 5493004J7H4GCPG6OB62 119573.08000000 GOLDMAN, SACHS & CO. 008-00129 000000361 FOR8UP27PHTHYVLBNG30 70457.81000000 MORGAN STANLEY & CO, INC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 19796.43000000 VIRTU FINANCIAL BD LLC 8-60815 000148390 54930088MP91YZQJT494 42704.31000000 SOCIETE GENERALE COWEN SECURITIES CORP. 008-40756 000023857 5493008QI0EFC5WBED75 38135.87999999 MKM PARTNERS 8-50311 000043552 54930015ODYESNP2QX15 18949.51000000 J.P. MORGAN SECURITIES 008-35008 000000079 ZBUT11V806EZRVTWT807 140492.83000000 MERRILL LYNCH, PIERCE, FENNER & SMITH 008-07221 000007691 8NAV47T0Y26Q87Y0QP81 7993.76000000 SUNTRUST 008-47518 000036888 IYDOJBGJWY9T8XKCSX06 11502.08000000 BLOOMBERG TRADEBOOK 008-49219 000040881 N/A 96788.04999999 596728.74000000 0.00 N 99754385.28000000 N N N N Highland/iBoxx Senior Loan ETF S000038289 N 100000.00000000 100.00000000 0.00000000 0.00000000 0.00000000 100.00000000 0.00000000 0.00000000 0.00000000 0.00000000 500.00000000 0.00000000 0.00000000 500.00000000 0.00000000 0.00000000 500.00000000 0.00000000 0.00000000 500.00000000 0.00000000 N false false true false false false INTERNAL CONTROL RPT 2 NCEN_HHOF.txt INTERNAL CONTROL LETTER REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Trustees of Highland Funds I In planning and performing our audit of the financial statements of Highland Funds I comprising Highland Healthcare Opportunities Fund and NexPoint Merger Arbitrage Fund (the Funds) as of and for the year ended June 30, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N?CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds internal control over financial reporting. Accordingly, we express no such opinion. The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A funds internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP). A funds internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a funds assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Funds annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Funds internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of June 30, 2021. This report is intended solely for the information and use of management and the Board of Trustees of the Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. COHEN & COMPANY, LTD. Cleveland, Ohio August 30, 2021 INTERNAL CONTROL RPT 3 NCEN_SNLN.txt INTERNAL CONTROL LETTER REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Trustees of Highland Funds I In planning and performing our audit of the financial statements of the Highland/iBoxx Senior Loan ETF (the Fund) as of and for the year ended June 30, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N?CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A funds internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP). A funds internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a funds assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Funds annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Funds internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of June 30, 2021. This report is intended solely for the information and use of management and the Board of Trustees of the Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. COHEN & COMPANY, LTD. Cleveland, Ohio August 30, 2021